ArticleBlood advances2024

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.

Aaron Etra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.